5:17 PM
 | 
Oct 04, 2013
 |  BC Extra  |  Company News

Atossa falls on recall news for breast health test

Atossa Genetics Inc. (NASDAQ:ATOS) fell $2.32 (44%) to $2.32 in early after-hours trading after announcing late Friday that it is recalling its Mammary Aspirate Specimen Cytology Test (MASCT) device and the accompanying ForeCYTE Breast Health Test. The device is cleared for use only...

Read the full 204 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >